Healthcare provider profile · identity verified

Erick Roman Kauffman, MD

Family Practice · CLEVELAND, OH · NPI 1447201256

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	373	111
Lisinopril	Lisinopril	260	77
Omeprazole	Omeprazole	221	55
Amlodipine Besylate	Amlodipine Besylate	220	66
Metformin Hcl	Metformin Hcl	195	55
Albuterol Sulfate Hfa	Albuterol Sulfate	184	48
Ibuprofen	Ibuprofen	169	36
Gabapentin	Gabapentin	165	43
Hydrochlorothiazide	Hydrochlorothiazide	150	40
Naproxen	Naproxen	143	25
Levothyroxine Sodium	Levothyroxine Sodium	129	32
Simvastatin	Simvastatin	127	26
Glipizide	Glipizide	99	24
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	93	22
Tamsulosin Hcl	Tamsulosin Hcl	86	25
Fluticasone Propionate	Fluticasone Propionate	85	23
Losartan Potassium	Losartan Potassium	85	25
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	83	20
Metoprolol Succinate	Metoprolol Succinate	78	21
Trazodone Hcl	Trazodone Hcl	77	27
Triamcinolone Acetonide	Triamcinolone Acetonide	75	20
Ozempic	Semaglutide	71	suppressed
Pantoprazole Sodium	Pantoprazole Sodium	71	14
Furosemide	Furosemide	70	18
Tramadol Hcl	Tramadol Hcl	66	19
Metoprolol Tartrate	Metoprolol Tartrate	62	15
Trulicity	Dulaglutide	56	15
Spiriva Respimat	Tiotropium Bromide	54	suppressed
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	53	13
Atenolol	Atenolol	51	14
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	48	suppressed
Rosuvastatin Calcium	Rosuvastatin Calcium	48	16
Tizanidine Hcl	Tizanidine Hcl	48	suppressed
Buspirone Hcl	Buspirone Hcl	45	suppressed
Diclofenac Sodium	Diclofenac Sodium	45	13
Clopidogrel	Clopidogrel Bisulfate	44	11
Famotidine	Famotidine	44	11
Montelukast Sodium	Montelukast Sodium	44	11
Citalopram Hbr	Citalopram Hydrobromide	40	suppressed
Lovastatin	Lovastatin	38	suppressed
Prednisone	Prednisone	37	20
Alendronate Sodium	Alendronate Sodium	36	13
Carvedilol	Carvedilol	36	12
Metformin Hcl Er	Metformin Hcl	36	suppressed
Zolpidem Tartrate	Zolpidem Tartrate	36	suppressed
Bupropion Xl	Bupropion Hcl	35	suppressed
Ibu	Ibuprofen	34	suppressed
Hydroxyzine Hcl	Hydroxyzine Hcl	33	suppressed
Potassium Chloride	Potassium Chloride	32	suppressed
Pravastatin Sodium	Pravastatin Sodium	32	suppressed
Sertraline Hcl	Sertraline Hcl	32	suppressed
Warfarin Sodium	Warfarin Sodium	31	suppressed
Clonazepam	Clonazepam	29	suppressed
Quetiapine Fumarate	Quetiapine Fumarate	29	suppressed
Meloxicam	Meloxicam	28	suppressed
Risperidone	Risperidone	28	suppressed
Paroxetine Hcl	Paroxetine Hcl	27	suppressed
Symbicort	Budesonide/Formoterol Fumarate	27	suppressed
Oxycodone-Acetaminophen	Oxycodone Hcl/Acetaminophen	26	suppressed
Sumatriptan Succinate	Sumatriptan Succinate	26	suppressed
Venlafaxine Hcl Er	Venlafaxine Hcl	26	suppressed
Buprenorphine-Naloxone	Buprenorphine Hcl/Naloxone Hcl	25	suppressed
Chlorthalidone	Chlorthalidone	25	suppressed
Esomeprazole Magnesium	Esomeprazole Magnesium	25	suppressed
Sucralfate	Sucralfate	25	suppressed
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	25	suppressed
Alcohol Prep Pads	Alcohol Antiseptic Pads	24	suppressed
Allopurinol	Allopurinol	24	suppressed
Alprazolam	Alprazolam	24	suppressed
Amitriptyline Hcl	Amitriptyline Hcl	24	suppressed
Fluoxetine Hcl	Fluoxetine Hcl	24	suppressed
Ondansetron Hcl	Ondansetron Hcl	24	suppressed
Duloxetine Hcl	Duloxetine Hcl	23	suppressed
Pregabalin	Pregabalin	23	suppressed
Acetaminophen-Codeine	Acetaminophen With Codeine	22	suppressed
Lansoprazole	Lansoprazole	22	suppressed
Qvar Redihaler	Beclomethasone Dipropionate	21	suppressed
Valacyclovir	Valacyclovir Hcl	21	suppressed
Ventolin Hfa	Albuterol Sulfate	21	suppressed
Dextroamphetamine-Amphetamine	Dextroamphetamine/Amphetamine	20	suppressed
Mounjaro	Tirzepatide	20	suppressed
Amoxicillin	Amoxicillin	19	14
Pioglitazone Hcl	Pioglitazone Hcl	19	suppressed
Topiramate	Topiramate	19	suppressed
Clindamycin Phosphate	Clindamycin Phosphate	18	suppressed
Creon	Lipase/Protease/Amylase	18	suppressed
Hydralazine Hcl	Hydralazine Hcl	18	suppressed
Insulin Lispro	Insulin Lispro	18	suppressed
Novolog Mix 70-30 Flexpen	Insulin Aspart Prot/Insuln Asp	18	suppressed
Valsartan	Valsartan	18	suppressed
Escitalopram Oxalate	Escitalopram Oxalate	17	suppressed
Prochlorperazine Maleate	Prochlorperazine Maleate	17	suppressed
Spironolactone	Spironolactone	17	suppressed
Ciclopirox	Ciclopirox	16	suppressed
Farxiga	Dapagliflozin Propanediol	16	suppressed
Dulera	Mometasone/Formoterol	15	suppressed
Fluticasone-Salmeterol	Fluticasone Propion/Salmeterol	15	suppressed
Insulin Lispro Kwikpen U-100	Insulin Lispro	15	suppressed
Cilostazol	Cilostazol	14	suppressed
Ezetimibe	Ezetimibe	14	suppressed
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	14	suppressed
Oxybutynin Chloride	Oxybutynin Chloride	14	suppressed
Synthroid	Levothyroxine Sodium	14	suppressed
Ultra-Fine Mini Pen Needle	Pen Needle, Diabetic	14	suppressed
Celecoxib	Celecoxib	13	suppressed
Doxepin Hcl	Doxepin Hcl	13	suppressed
Fenofibrate	Fenofibrate	13	suppressed
Jardiance	Empagliflozin	13	suppressed
Morphine Sulfate Er	Morphine Sulfate	13	suppressed
Nitroglycerin	Nitroglycerin	13	suppressed
Omega-3 Acid Ethyl Esters	Omega-3 Acid Ethyl Esters	13	suppressed
Pro Comfort Alcohol Pads	Alcohol Antiseptic Pads	13	suppressed
Varenicline Tartrate	Varenicline Tartrate	13	suppressed
Xarelto	Rivaroxaban	13	suppressed
Eliquis	Apixaban	12	suppressed
Isosorbide Mononitrate Er	Isosorbide Mononitrate	12	suppressed
Mirtazapine	Mirtazapine	12	suppressed
Nano 2nd Gen Pen Needle	Pen Needle, Diabetic	12	suppressed
Testosterone Cypionate	Testosterone Cypionate	12	suppressed
Tretinoin	Tretinoin	12	suppressed
Eszopiclone	Eszopiclone	11	suppressed
Finasteride	Finasteride	11	suppressed
Venlafaxine Hcl	Venlafaxine Hcl	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error